![]() |
|
|
Vol. 61, Issue 4, 832-839, April 2002
-carbonitrile Is via Interaction with Pregnane X
Receptor
Department of Pharmacology, Toxicology, and Therapeutics,
University of Kansas Medical Center, Kansas City, Kansas
The rat organic anion transporting polypeptide 2 (oatp2; Slc21a5) is a
liver transporter that mediates the uptake of a variety of structurally
diverse compounds, and has a high affinity for cardiac glycosides.
Treatment of rats with pregnenolone-16
-carbonitrile (PCN), a ligand
for the rodent pregnane X receptor (PXR), significantly enhances the
rat oatp2 gene expression. To understand the molecular mechanism of
oatp2 induction by PCN, rat oatp2 gene was cloned. The rat oatp2 gene
consists of 16 exons; alternative splicing of the second noncoding exon
gives rise to the two published rat oatp2 cDNAs. Approximately 8700 base pairs (bp) of the 5'-flanking region of the rat oatp2 gene were
linked to the luciferase reporter gene and used in transient
transfection assays in H4IIE cells. Treatment of PCN induced the
expression of the reporter gene in a dose-dependent manner. Four
potential PXR response elements (PXREs) were identified in the
5'-flanking region of the rat oatp2 gene. One element (DR3-1) is
located approximately
5000 bp with three more (DR3-2, DR3-3, and
DR3-4) clustered at about
8000 bp. Results from electrophoretic
mobility shift assays showed that the PXR-retinoid X receptor
heterodimer binds to the DR3-2 with the highest affinity, to
the DR3-4 and DR3-1 with a lower affinity, and weakly or not at all to
the DR3-3. Furthermore, a series of partial deletions of the
5'-flanking region illustrated that both the proximal and distal
clusters of PXREs are required for maximal induction of rat oatp2 by
PCN. In conclusion, these data elucidate the molecular mechanism by
which PCN treatment induces rat oatp2 gene expression. In addition,
this study identifies rat oatp2 as a direct PXR-targeted gene and
further supports the hypothesis that activation of PXR affects a
network of genes that is involved in either metabolism or transport of
drugs, steroids, and bile acids.
This article has been cited by other articles:
![]() |
T. Wang, X. Ma, K. W. Krausz, J. R. Idle, and F. J. Gonzalez Role of Pregnane X Receptor in Control of All-Trans Retinoic Acid (ATRA) Metabolism and Its Potential Contribution to ATRA Resistance J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 674 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Donner, S. Schumacher, U. Warskulat, J. Heinemann, and D. Haussinger Obstructive cholestasis induces TNF-{alpha}- and IL-1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2 Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1134 - G1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Maeda, M. Oyabu, T. Yotsumoto, R. Higashi, K. Nagata, Y. Yamazoe, and I. Tamai Effect of Pregnane X Receptor Ligand on Pharmacokinetics of Substrates of Organic Cation Transporter Oct1 in Rats Drug Metab. Dispos., September 1, 2007; 35(9): 1580 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ma, Y. M. Shah, G. L. Guo, T. Wang, K. W. Krausz, J. R. Idle, and F. J. Gonzalez Rifaximin Is a Gut-Specific Human Pregnane X Receptor Activator J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 391 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Pacyniak, X. Cheng, M. L. Cunningham, K. Crofton, C. D. Klaassen, and G. L. Guo The Flame Retardants, Polybrominated Diphenyl Ethers, Are Pregnane X Receptor Activators Toxicol. Sci., May 1, 2007; 97(1): 94 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Shah, X. Ma, K. Morimura, I. Kim, and F. J. Gonzalez Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-{kappa}B target gene expression Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1114 - G1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen, X. Cheng, M. Z. Dieter, Y. Tanaka, and C. D. Klaassen Activation of cAMP-Dependent Signaling Pathway Induces Mouse Organic Anion Transporting Polypeptide 2 Expression Mol. Pharmacol., April 1, 2007; 71(4): 1159 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Moore, S. Kato, W. Xie, D. J. Mangelsdorf, D. R. Schmidt, R. Xiao, and S. A. Kliewer International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor {alpha}, Farnesoid X Receptor beta, Liver X Receptor {alpha}, Liver X Receptor beta, and Vitamin D Receptor Pharmacol. Rev., December 1, 2006; 58(4): 742 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cheng and C. D. Klaassen Regulation of mRNA Expression of Xenobiotic Transporters by the Pregnane X Receptor in Mouse Liver, Kidney, and Intestine Drug Metab. Dispos., November 1, 2006; 34(11): 1863 - 1867. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cheng, J. Maher, H. Lu, and C. D. Klaassen Endocrine Regulation of Gender-Divergent Mouse Organic Anion-Transporting Polypeptide (Oatp) Expression Mol. Pharmacol., October 1, 2006; 70(4): 1291 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gu, S. Ke, D. Liu, T. Sheng, P. E. Thomas, A. B. Rabson, M. A. Gallo, W. Xie, and Y. Tian Role of NF-{kappa}B in Regulation of PXR-mediated Gene Expression: A MECHANISM FOR THE SUPPRESSION OF CYTOCHROME P-450 3A4 BY PROINFLAMMATORY AGENTS J. Biol. Chem., June 30, 2006; 281(26): 17882 - 17889. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Geier, C. G. Dietrich, S. Voigt, M. Ananthanarayanan, F. Lammert, A. Schmitz, M. Trauner, H. E. Wasmuth, D. Boraschi, N. Balasubramaniyan, et al. Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G831 - G841. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cheng, J. Maher, M. Z. Dieter, and C. D. Klaassen REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDES (OATPS) IN LIVER BY PROTOTYPICAL MICROSOMAL ENZYME INDUCERS THAT ACTIVATE DISTINCT TRANSCRIPTION FACTOR PATHWAYS Drug Metab. Dispos., September 1, 2005; 33(9): 1276 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Ferguson, Y. Chen, E. L. LeCluyse, M. Negishi, and J. A. Goldstein Human CYP2C8 Is Transcriptionally Regulated by the Nuclear Receptors Constitutive Androstane Receptor, Pregnane X Receptor, Glucocorticoid Receptor, and Hepatic Nuclear Factor 4{alpha} Mol. Pharmacol., September 1, 2005; 68(3): 747 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Augustine, R. J. Markelewicz Jr., K. Boekelheide, and N. J. Cherrington XENOBIOTIC AND ENDOBIOTIC TRANSPORTER MRNA EXPRESSION IN THE BLOOD-TESTIS BARRIER Drug Metab. Dispos., January 1, 2005; 33(1): 182 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Guo, J. S. Moffit, C. J. Nicol, J. M. Ward, L. A. Aleksunes, A. L. Slitt, S. A. Kliewer, J. E. Manautou, and F. J. Gonzalez Enhanced Acetaminophen Toxicity by Activation of the Pregnane X Receptor Toxicol. Sci., December 1, 2004; 82(2): 374 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. St-Pierre, T. Stallmach, A. Freimoser Grundschober, J.-F. Dufour, M. A. Serrano, J. J. G. Marin, Y. Sugiyama, and P. J. Meier Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1505 - R1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bauer, A. M. S. Hartz, G. Fricker, and D. S. Miller Pregnane X Receptor Up-Regulation of P-Glycoprotein Expression and Transport Function at the Blood-Brain Barrier Mol. Pharmacol., September 1, 2004; 66(3): 413 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Z. Turncliff, P. J. Meier, and K. L. R. Brouwer EFFECT OF DEXAMETHASONE TREATMENT ON THE EXPRESSION AND FUNCTION OF TRANSPORT PROTEINS IN SANDWICH-CULTURED RAT HEPATOCYTES Drug Metab. Dispos., August 1, 2004; 32(8): 834 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Hartley, X. Dai, Y. D. He, E. J. Carlini, B. Wang, S.-e. W. Huskey, R. G. Ulrich, T. H. Rushmore, R. Evers, and D. C. Evans Activators of the Rat Pregnane X Receptor Differentially Modulate Hepatic and Intestinal Gene Expression Mol. Pharmacol., May 1, 2004; 65(5): 1159 - 1171. [Abstract] [Full Text] |
||||
![]() |
R. G. Tirona, B. F. Leake, L. M. Podust, and R. B. Kim Identification of Amino Acids in Rat Pregnane X Receptor that Determine Species-Specific Activation Mol. Pharmacol., January 1, 2004; 65(1): 36 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Handschin and U. A. Meyer Induction of Drug Metabolism: The Role of Nuclear Receptors Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama Impact of Drug Transporter Studies on Drug Discovery and Development Pharmacol. Rev., September 1, 2003; 55(3): 425 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen, J. L. Staudinger, and C. D. Klaassen NUCLEAR RECEPTOR, PREGNANE X RECEPTOR, IS REQUIRED FOR INDUCTION OF UDP-GLUCURONOSYLTRANSFERASES IN MOUSE LIVER BY PREGNENOLONE-16{alpha}-CARBONITRILE Drug Metab. Dispos., July 1, 2003; 31(7): 908 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Walter, C. Ullmann, D. Thummler, and W. Siegmund INFLUENCE OF PROPIVERINE ON HEPATIC MICROSOMAL CYTOCHROME P450 ENZYMES IN MALE RATS Drug Metab. Dispos., June 1, 2003; 31(6): 714 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sonoda, W. Xie, J. M. Rosenfeld, J. L. Barwick, P. S. Guzelian, and R. M. Evans Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR) PNAS, October 15, 2002; 99(21): 13801 - 13806. [Abstract] [Full Text] [PDF] |
||||